Close Alert

COVID-19 Update

USciences implements virtual education, telecommuting in response to Coronavirus (COVID-19). More information at

Medical Cannabis 4-hour Certification Course

Medical Cannabis: Clinical Considerations and Dispensing in PA (4 continuing education hours)

Saturday, February 15, 2020

University of the Sciences
McNeil Science and Technology Center (STC), 145
42nd Street and Woodland Avenue
Philadelphia, PA 19104

Map, directions and parking information

Register Now


Registration:  7:45 am
Course:  8:00 am–12:15 pm (includes a 15 minute break)

Presenting Faculty

  • Christine Roussel, PharmD, BCOP, Director of Pharmacy, Doylestown Hospital, PA
  • Adam C. Lake, MD, FAAFP, AAHIVS, FACMQ, Penn LGHealth in Lancaster, PA
  • Maria Foy, PharmD, BCPS, CPE, Clinical Pharmacy Specialist, Abington Hospital, Jefferson Health

More information about faculty and disclosures.

Certification Course Description

Medical Cannabis: Clinical Considerations and Dispensing in PA  (4 hours)



The purpose of this program is to educate physicians, pharmacists, certified registered nurse practitioners or physician assistants seeking to register with the Pennsylvania Department of Health’s Medical Marijuana Program. All health professionals interested in learning more about medical cannabis are also encouraged to take this course.


  1. Explain the status of cannabis as a controlled substance in the US under federal law as well as the state to state variability in medical cannabis laws
  2. Identify cannabinoid receptors and the non-phytocannabinoid constitutes of cannabis
  3. Describe key features of the endocannabinoid system and cannabis pharmacology
  4. Discuss best practices in patient evaluation, medical marijuana product choice and dosage, and therapeutic monitoring
  5. Explain how possible concurrent opioid use, risk management, and palliative care considerations impact patient pain management clinical care
  6. Recognize potential drug interactions, side effects, and the potential for addiction from medical cannabis use



Pharmacists: ACPE Credits for this knowledge based program will be awarded and submitted for all pharmacist attendees who register & attest to their active attendance through the webcast platform, complete the evaluation form, successfully complete the post-test, and submit their NABP ePID and DOB verifier (MMDD). 100% attendance is required.



Alpha Zeta Omega National Pharmaceutical Fraternity, Philadelphia Alumni Chapter is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Logo - Jointly Accredited Provider, Interprofessional Continuing EducationPhysicians:  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Substance Use Disorder Institute.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 4 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available.  If you are seeking continuing education credit for a specialty not listed, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Acknowledgment of Financial or In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Refund Policy

No refunds. You may transfer your registration to an alternate participant or apply the fee amount towards a future certification course, with advance notice and if available.



USciences Substance Use Disorders Institute logo


Andrew M. Peterson, PharmD, PhD, FCPP
Executive Director, Substance Use Disorders Institute


University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495